Document details
Form
Filing Date
Sep 2, 2026
Document Date
Sep 1, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Olema Oncology
Issuer
Olema Pharmaceuticals, Inc.
Filer
O'BYRNE JASON